The FDA gave compounders a grace period to wind down their production of the drugs after the shortage was over. Small pharmacies had until February 18 to comply, while larger outsourcing facilities had until March 19. (Semaglutide compounders were ordered to cease mass production this spring, with smaller compounders given …
Read More »Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
